RLRadu Lefter

Radu Lefter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Radu Lefter has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Calcium-Orchestrated Vascular Collapse in Cancer Therapy: Mechanisms, Nanotherapeutic Platforms, and Translational Perspectives

    by Fatima Zahra Kamal, Radu Lefter, Vasile Burlui, Alin Stelian Ciobîcă, Gabrielle Dăscălescu, Said Rammali, Andrei Luca, Ancuța Andreea Miler, Hina Alim, Otilia Novac, et al.

    Cancer therapy is increasingly focused on manipulating the tumor microenvironment rather than directly eradicating malignant cells. Vascular-targeting strategies are emerging, and calcium-mediated vascular disruption is an exciting approach through which rapid and irreversible blood flow shutdown can be achieved. Here, we overview the molecular and physiological basis of calcium signaling in vascular homeostasis and outline how unregulated calcium dysfunctions in endothelial cells compromise their functionality and represent therapeutic opportunities. Elevation of intracellular calcium concentrations in endothelial cells promotes their dysfunction, coagulation, mitochondrial collapse, oxidative stress, and ultimately apoptosis, resulting in catastrophic vascular depletion and secondary necrosis that follows such collapse. A promising area of calcium-mediated attack is the emergence of exciting nanotechnologies that result in the development of calcium phosphate, calcium carbonate, and calcium peroxide nanoparticles, exploiting the enhanced permeability and retention effect of nanoparticle therapeutics to achieve selective tumor accumulation and controlled calcium release. Indeed, hybrid therapeutic platforms that couple calcium dysregulation with chemotherapy, photodynamic therapy, sonodynamic therapy, immunotherapy, or thermal ablation can exhibit pronounced antitumor effects through synergistic means. There is good preclinical evidence for the feasibility of vascular collapse mediated via calcium dysregulation. The transition of calcium to the clinic faces hurdles in relation to biosafety, how to achieve precise delivery, pharmacokinetics, and regulatory harmonization. Compared to traditional vascular disrupting agents and anti-angiogenic therapies, calcium modalities can provide rapid occlusion of vessels, are less prone to resistance development, and potentially have less systemic toxicity. Overall, calcium-mediated vascular collapse is thus an exciting next-generation technology for the vascular-targeted treatment of cancer, and likely to play an important role in precision oncology therapeutics.

  • Open Access

    Advances in Nanotechnology - Engineered Exosomes for Early Biomarker Detection and Therapy in Alzheimer’s Disease

    by Fatima Zahra Kamal, Radu Lefter, Ioannis Mavroudis, Alin Ciobica, Bogdan Novac, Otilia Novac, Said Rammali, Vasile Burlui, Daniela Ivona Tomita

    Advances in the understanding of exosome biology have led to their recognition as the heart of intercellular communications. Additionally, the new insights into the role of exosomes in neuroinflammation and spreading of characteristic Alzheimer’s Disease (AD) pathologies, open the scope for their use as a key target for diagnostic and therapeutic innovation. The immuno-engineering platforms are sensitive for detecting exosomal biomarkers including amyloid-β species, phosphorylated tau, and regulatory microRNAs, in peripheral biofluids with minimal invasion. Hence, these are potential platforms that can facilitate early diagnosis of AD. Although most supporting evidence is presently derived based on preclinical models and limited observational cohorts, these findings support minimally invasive opportunities for early disease monitoring and diagnosis, possibly even before the manifestation of clinical symptoms of AD. Alongside, another advantage of engineered exosomes is their flexible framework for targeted drug delivery. Since engineered exosomes are derived from neuronal or mesenchymal stem cells, they can cross the blood-brain barrier and deliver neuroprotective or immunomodulatory agents with high specificity. Presently, the target precision and off-target biodistribution of engineered exosomes are one of the most active areas of investigation. More encouragingly, incorporating nanotechnology for surface modification and cargo loading strategies can further enhance exosomal signaling, delivery efficiency, and cell-specific uptake by neuronal and glial cells. These applications, however, are presently challenging in terms of scalability and reproducibility. Also, a number of advancements are needed in areas of standardization of exosome isolation, scalable manufacturing, regulatory frameworks, and biological heterogeneity. Overcoming these challenges, however, is feasible with the integration of Artificial Intelligence and multi-omics profiling, and optimisation of exosome-based interventions.

  • Open Access

    A Preliminary View on Using AI and Computational Science for Observing Predictive Factors in Conservative Treatment of Cervical Intraepithelial Neoplasia

    by Maria Diana Focșa, Radu Lefter, Mihaela Tomaziu-Todosia, Bogdan Novac, Otilia Novac, Ecaterina Tomaziu-Todosia Anton

    Cervical intraepithelial neoplasia (CIN) represents a range of precancerous lesions, with abnormal cell growth on the epithelium of the cervix, the lower part of the uterus that connects to the vagina caused almost entirely by human papillomavirus (HPV). Detection and diagnosis of cervical cancer, currently based on colposcopy-guided biopsy involving clinical examination and imaging procedures, will most certainly benefit from the application of AI-assisted technology and AI algorithms in the image analysis, for automated cervical cytology, colposcopy examinations, predicting the cervical cancer, and the progression of risk calculation.

  • Open Access

    Eugenol Nanoparticles in Dental Composites: Literature Review of Antimicrobial, Anti-Inflammatory, and Clinical Applications

    by Fatima Zahra Kamal, Alin Ciobica, Gabriel Dascalescu, Said Rammali, Mohamed El Aalaoui, Radu Lefter, Ioana Vata, Vasile Burlui, Bogdan Novac

    The formation of microbial colonies and biofilms are common on dental restorations. This can lead to secondary caries. Another common complication is the post-operative inflammation noted in patients. The traditionally used dental composites are designed without the inherent components having antimicrobial and inflammatory properties. This has become a major challenge in current restorative dentistry applications. In order to address these challenges, a possible approach is to incorporate eugenol nanoparticles (NPs) into dental composites. This approach can offer dual therapeutic benefits since eugenol possess both antimicrobial and inflammatory properties. In fact, compared to synthetic antimicrobial agents, eugenol exhibits antibacterial activity not only against Streptococcus mutans but also against a range of oral pathogens. It also exhibits anti-inflammatory effects that can promote healing by reducing post-operative sensitivity. In spite of the above benefits, eugenol cannot be incorporated directly into dental materials. This is because eugenol is highly volatile and has poor water solubility. The encapsulation of eugenol in suitable nano-materials can overcome these limitations. In addition, it can enable the controlled and sustained release of desirable agents for long-term therapeutic action. In this review, we explore the mechanisms, advantages and potential clinical applications of dental composites containing NP integrated with eugenol. We highlight the advantages of having antimicrobial and anti-inflammatory functions in a single restorative material. At the same time, we acknowledge the need for more in-depth research to optimize NP formulations with eugenol that does not compromise the mechanical properties of dental materials. Based on a thorough literature review, we believe that this approach has much potential in restorative dentistry procedures that will aid therapeutic outcomes in the future.


  • Open Access

    Assessing the Influence of Low Doses of Sucrose on Memory Deficits in Fish Exposed to Common Insecticide Based on Fipronil and Pyriproxyfen

    by Viorica Rarinca, Luminita Diana Hritcu, Marian Burducea, Gabriel Plavan, Radu Lefter, Vasile Burlui, Laura Romila, Alin Ciobică, Elena Todirascu-Ciornea, Cristian-Alin Barbacariu

    Although pesticides have been a constant concern for decades, in the last ten years, public discussions and scientific research have emphasized their impact on human health and the environment, drawing increased attention to the problems associated with their use. The association of environmental stressors such as pesticides with a sugar-rich diet can contribute to the growing global metabolic disease epidemic through overlapping mechanisms of insulin resistance, inflammation, and metabolic dysregulation. The main aim of this study was to evaluate the behavioral effects of the exposure of Silver crucian carp (Carassius auratus gibelio) to a commercial insecticide formulation containing fipronil, pyriproxyfen, and other additives, as well as sucrose and their mixtures. The behavioral responses in the T-test showed significant abnormalities in the exploratory activity evocative of memory deficits and an increased degree of anxiety in the groups of fish treated with the insecticide formulation and the mixture of the insecticide with sucrose. Aggression, quantified in the mirror-biting test, as biting and the frequency of approaches to the mirror contact zone, was significantly decreased only in the insecticide and sucrose group. All three groups showed behavioral changes reflective of toxicity, but only the combination of the two stress factors, environmental (insecticide) and metabolic (sucrose intake), resulted in pronounced memory alterations.

  • Clustering 3D Tracking in Zebrafish Laboratory Trials

    by Adrian Valentin Panaintescu, Vlad Constantin Craciun, Radu Marian Lefter, Luca Mihaela

    Due to the significant genetic similarities between zebrafish (Danio rerio) and humans, researchers are increasingly utilizing this species to develop novel therapies for various health conditions by analysing their behaviour across healthy and treated subjects. The current workflow in laboratory trials typically involves a small number of fish subjects, leading to simplified behavioural models where One-way ANOV A is often sufficient to meet statistical requirements. In this study, we propose an alternative approach to understanding fish behaviour. Our methodology begins with two datasets of 3D video recordings (95 zebrafish and 80 goldfish samples), followed by the application of the KMeans clustering and HMM (Hidden Markov Models) classification algorithms to time-series data derived from 3D tracking features.

  • Open Access

    Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil

    by Said Rammali, Fatima Zahra Kamal, Mohamed El Aalaoui, Abdellatif Rahim, Aziz Baidani, Khadija Dari, Abdelkrim Khattabi, Alin Ciobică, Bogdan Novac, Antoneta Petroaie, et al.

    Antibiotics play a crucial role in preserving and improving public health, saving millions of lives every year. However, their effectiveness is currently under threat due to the ability of bacteria to adapt and develop resistance to these treatments. Therefore, this study was carried out on two soil samples collected in two areas of Arba Aounate, Sidi Bennour province, Morocco, to identify natural antibiotic-producing Actinobacteria capable of combating multi-drug-resistant (MDR) bacteria. A primary screening revealed that of the 50 isolates, 16 exhibited antimicrobial activity against Pseudomonas aeruginosa ATCC 27,853, Staphylococcus aureus ATCC 25,923, Escherichia coli ATCC 25,922, and Candida albicans ATTC 60193. A secondary screening showed that of the 16 isolates, only EIZ1 and EIZ2 isolates displayed outstanding antimicrobial and antifungal activity against 6 MDR bacteria, including Escherichia coli 19L2418, Listeria monocytogenes, Proteus sp. 19K1313, Klebsiella pneumoniae 19K 929, Proteus vulgaris 16C1737, and Klebsiella pneumoniae 20B1572. These two isolates were also characterized culturally, morphologically, physiologically, and biochemically. Afterward, the amplification of 16S rRNA revealed that isolate EIZ2 was 99.06% strongly related to the genus Streptomyces. Furthermore, this extract exhibits strong antioxidant activity against DPPH and ABTS free radicals and elevated ferric-reducing antioxidant power. A significant (p < 0.0001) positive correlation was observed between antioxidant activities and total phenolic and flavonoid contents. A GC–MS analysis of the ethyl acetate extract revealed the presence of 10 compounds, mainly diethyl phthalate (97%) and benzeneacetic acid (94%). This research demonstrates that Streptomyces sp. strain EIZ2 represents a potential source of antimicrobial and antioxidant compounds. These compounds could offer considerable potential as therapeutic agents, paving the way for future developments in medical applications.


  • Open Access

    Polysaccharides and Lectins: A Natural Complementary Approach against the SARS-CoV-2 Pandemic

    by Radu Lefter, Prairna Balyan, Ioana-Miruna Balmus, Abdellah Ech-Chahad, Ahmad Ali, Alin Ciobica, Antoneta Dacia Petroaie, Gabriela Halitchi, Bogdan Novac, Catalina Ionescu, et al.

    Infection with the novel coronavirus SARS-CoV-2, the cause of coronavirus disease (COVID-19), has emerged as a global pandemic, with a high toll on casualties, economic impact, and human lifestyle. Despite the recent approval of various vaccines against the virus, challenges remain, including the limited availability of these vaccines, the prevalent rejection of vaccination by a large proportion of the population, and the recurrent appearance of new variants of the virus due to mutations. This context raises the alarm for scientists and clinicians to seek alternative and complementary therapies. In this context, natural products and their derivatives serve as reservoirs for potential therapeutic compounds that can be exploited in the research and production of antiviral drugs against COVID-19. Among these substances, lectin and polysaccharides isolated from fauna and flora emerge as complementary strategies for treating coronavirus infection. The review objective is to cover and analyze the specific role of polysaccharides and lectins and their synergy in the fight against this deadly SARS-CoV-2 virus. For this purpose, a primary literature search was conducted on Google Scholar, PubMed, and Web of Sciences using relevant keywords like “SARS-CoV-2 Variants”; “Antiviral Strategies”; “Antiviral Polysaccharides”; “Antiviral Lectins”; and “Synergistic effect”. The results demonstrate that lectins and polysaccharides exhibit antiviral activities against SARS-CoV-2 via mechanisms related to binding and steric blocking, the binding of glycan-based decoys, chemical reactions, virus particle disruption strategies, and steric blocking for competitive inhibition to block SARS-CoV-2 and its variants’ entry. In addition, this review analyzes the rationale behind combining polysaccharides and lectins, emphasizing complementary mechanisms of action. By simultaneously targeting multiple stages of the viral life cycle, this dual strategy aims to comprehensively inhibit viral propagation and enhance the durability of antiviral strategies over time.


  • Open Access

    Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia

    by Daniela-Carmen Ababei, Veronica Bild, Ioana Macadan, Alexandru Vasincu, Răzvan-Nicolae Rusu, Mihaela Blaj, Gabriela Dumitrița Stanciu, Radu-Marian Lefter, Walther Bild

    The Renin–Angiotensin System (RAS) has attracted considerable interest beyond its traditional cardiovascular role due to emerging data indicating its potential involvement in neurodegenerative diseases, including Alzheimer’s dementia (AD). This review investigates the therapeutic implications of RAS modulators, specifically focusing on angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and renin inhibitors in AD. ACEIs, commonly used for hypertension, show promise in AD by reducing angiotensin (Ang) II levels. This reduction is significant as Ang II contributes to neuroinflammation, oxidative stress, and β-amyloid (Aβ) accumulation, all implicated in AD pathogenesis. ARBs, known for vasodilation, exhibit neuroprotection by blocking Ang II receptors, improving cerebral blood flow and cognitive decline in AD models. Renin inhibitors offer a novel approach by targeting the initial RAS step, displaying anti-inflammatory and antioxidant effects that mitigate AD degeneration. Preclinical studies demonstrate RAS regulation’s favorable impact on neuroinflammation, neuronal damage, cognitive function, and Aβ metabolism. Clinical trials on RAS modulators in AD are limited, but with promising results, ARBs being more effective that ACEIs in reducing cognitive decline. The varied roles of ACEIs, ARBs, and renin inhibitors in RAS modulation present a promising avenue for AD therapeutic intervention, requiring further research to potentially transform AD treatment strategies.